Results from the phase-Ib/II combination trial MPNSG-0212 : Ruxolitinib plus pomalidomide in myelofibrosis with anemia

Authors :: Stegelmann, F.
Koschmieder, S.
Heidel, F.
Hochhaus, A.
Hebart, H.
Isfort, S.
Reiter, A.
Bangerter, M.
Waller, C.
Wolleschak, D.
Scheid, C.
Göthert, Joachim
Schafhausen, P.
Kindler, T.
Radsak, M. P.
Gattermann, N.
Möhle, R.
von Bubnoff, N.
Brümmendorf, T. H.
Döhner, H.
Griesshammer, M.
Döhner, K.
Publication Year :: 2021
Abstract: Poster-Abstract

Tools